Page last updated: 2024-09-02

ramosetron and Cancer of Rectum

ramosetron has been researched along with Cancer of Rectum in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jeong, SY; Kim, MJ; Kwon, YH; Lee, DW; Lee, MA; Moon, SH; Park, JW; Park, KJ; Ryoo, SB1

Trials

1 trial(s) available for ramosetron and Cancer of Rectum

ArticleYear
Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer.
    The British journal of surgery, 2021, 06-22, Volume: 108, Issue:6

    Topics: Benzimidazoles; Humans; Male; Middle Aged; Proctectomy; Rectal Neoplasms; Rectum; Serotonin 5-HT3 Receptor Antagonists; Syndrome; Treatment Outcome

2021